List of participants — 2026

Rostec is the largest industrial corporation in Russia and includes more than 800 enterprises with over 800,000 specialists. The company fulfills state tasks to ensure the country’s technological sovereignty in various industries, including healthcare. The corporation’s portfolio includes 200 types of products for neonatology, surgery, oncology, ophthalmology, and other areas of medicine, as well as 150 immunobiological products. Their production involves our companies Shvabe, KRET, Rosel, OneCell, Nacimbio, and others. The National Air Ambulance Service, established by the Corporation, provides emergency patient evacuation in 54 regions of the country. The Center for Innovation in Traumatology and Orthopedics (CITO) produces advanced prosthetic devices and opens rehabilitation centers. Rostec builds and equips modern clinics and invests in scientific research. By 2030, the corporation plans to release 40 new medical products and quadruple its presence in the healthcare market.

Contact information
Website: https://rostec.ru/en/

Nacimbio is a pharmaceutical holding company established by Rostec State Corporation in 2013 to advance the production of immunobiological medicinal products that are critical to Russia’s national security.

The company brings together two of Russia’s leading pharmaceutical manufacturers— NPO Microgen and FORT. Nacimbio’s activities include the research, development, full-cycle manufacturing, and commercialization of vaccines and toxoids, blood products, bacteriophages, allergens, allergoids, and other pharmaceutical products.

Contact information
Website: https://nacimbio.ru/en/

A7 is a global financial technology company specializing in international payments and settlement solutions for international trade. It was established in 2024 with the involvement of PSB Bank.

A7 is developing an independent global payment infrastructure across more than 100 countries, combining global financial expertise, advanced technology and regulatory compliance. The company’s products include international payments, digital financial assets and promissory notes.

A7 Group works with 15,000 clients, with around 2,000 transactions processed through the system every day. In 2025, approximately 19% of Russian companies’ cross-border trade settlements were processed through A7. In October 2025, A7 received an AA(RU) credit rating with a Stable outlook from ACRA.

Contact information
Website: www.a7.ru

Arnest UniRus LLC is one of the largest manufacturers of fast moving consumer goods in Russia. Arnest UniRus produces cosmetics, home care products, ice cream, food products and biologically active additives. The company operates on 9 large manufacturing sites: ice cream and food products in Tula region, ice cream in Omsk, cosmetics and home care products in St. Petersburg, cosmetics and packaging in Ekaterinburg, cosmetics and perfume in Naro-Fominsk, biologically active additives in Biysk. In April 2026, the company also launched production in Navoiy, Uzbekistan. Our factories are equipped with innovative, high-tech machines that meet the most modern requirements for industrial safety and efficiency.

Contact information
Website: https://www.unirusgroup.ru/

Magnit is the largest omnichannel retailer in Russia, leading the market in number of stores and geographical coverage. The Company has over 33,000 outlets in 5,000 Russian cities and towns as well as in the Republic of Uzbekistan. The Group also includes the Dixy, Azbuka Vkusa, Samberi, B1 retail chains. In addition to that, Magnit is also developing e-commerce services and fintech.

Magnit is a unique company in Russian retail. Besides selling goods, it produces groceries under its private labels. The Company operates 20 enterprises that cultivate mushrooms, vegetables, berries, apples and manufacture dry foods, confectioneries, and other products.

Magnit is also one of the largest private employers in Russia, with a total headcount of 388 thousand employees.

Contact information
Website: magnit.ru

The Moscow Center for Innovative Technologies in Healthcare, or Medtech. Moscow, was established at the initiative of the Mayor of Moscow in February 2022 to accelerate the development and integration of scientific innovations into clinical practice.

Here, Moscow physicians collaborate with scientists from leading Russian research institutions and startups to create new technologies and refine existing solutions for their rapid implementation in the city’s healthcare system. The Center supports scientific projects at every stage, including expert evaluation, patent protection, certification, regulatory approval, and the organization of serial production.

Key areas of focus include biotechnology, genetic and cellular technologies, the development of new materials and implants, 3D bioprinting, and artificial intelligence.

One of the central instruments for supporting innovative development is the Mayor of Moscow Grant Program, administered by Medtech since 2022.
Each year, more than 1 billion rubles are allocated for the development, testing, and implementation of advanced methods in diagnostics, treatment, and rehabilitation.

To date, 220 research projects have received support, some of which have been applied for the first time not only in Russia, but worldwide.

Medtech’s Technopark provides everything needed for the successful advancement of innovative medical technologies. Support programs available to residents and research teams help attract grants from federal and municipal development institutions, secure investment from Russian venture funds, and successfully navigate the medical technology registration process.

Contact information
Website: medtech.moscow
Email: mcitz@zdrav.mos.ru
Telegram: t.me/medtechmoscow
Vk: vk.com/medtechmoscow

PJSC «PROMOMED» is a leading innovative biopharmaceutical company with significant growth potential in promising segments of the pharmaceutical market. The company's structure includes its own unique world-class R&D center and a high–tech manufacturing facility — «BIOKHIMIK» plant. Thanks to this, PROMOMED implements the full-cycle production concept "from idea to molecule, from molecule to patient". The company is developing a diversified portfolio of over 370 medicines in the top 10 segments of the pharmaceutical market, including those that have no analogues in Russia. Based on its own developments, PROMOMED produces drugs for the treatment of socially significant diseases: oncological, neurological, rheumatic, infectious disease, diabetes mellitus, obesity, and others. The company is an active participant in the system ensuring national drug security and import independence.

Contact information
Website: promomed.pro/en/

R-Pharm Group introduces comprehensive solutions for the healthcare system and focuses on research, development, manufacturing and commercialization of pharmaceuticals, laboratory equipment and medical devices. R-Pharm's mission is to increase the accessibility of advanced diagnostics, preventative care and therapy methods in Russia and abroad.

R-Pharm’s 11 state-of-the-art manufacturing sites are functioning in accordance with international quality standards. The group has signed agreements on strategic partnership, production localization and technology transfer with the world's leading manufacturers of pharmaceuticals and medical equipment.

The most important activities of the group include research and development. Today, R-Pharm’s research pipeline contains more than 100 knowledge-intensive products, which makе a serious contribution to the fight against high burden diseases.

Following corporate social responsibility policies, R-Pharm organizes projects aiming to increase awareness about dangerous diseases, promote healthy lifestyle, improve the educational system and foster a new generation of professionals in the pharmaceutical industry.

Contact information
Website: www.r-pharm.com/en

BIOTECHNO LLC is a Russian leader in designing and manufacturing equipment for biotech, pharmaceutical, chemical, and food industries. For 25 years, the company has completed over 200 projects and supplied 1,000+ equipment units.

Production facilities in Moscow and Shchelkovo (3,000 m² total) cover the full cycle: engineering, machining, assembly, testing, and delivery.

Key products:
Laboratory, pilot, and industrial fermenters & bioreactors – a complete range from 3 to 2,000 liters for cell and microorganism cultivation. Features: unique lid with universal ports, precise control, and full aseptic operation.

Biotechno perfusion filtration system – for continuous cultivation, achieving cell densities tens of times higher than traditional methods. Shortlisted for the 2025 Industry Award (top 5).

Integrated lab-to-production lines – model upstream & downstream processes, enabling seamless scale‑up from R&D to industrial manufacturing.

All equipment is made of AISI 316L stainless steel, meets international standards, and supports Russia's technological sovereignty in biopharmaceuticals.

Contact information
Website: www.biotechno.ru
Email: moscow@biotechno.ru
Phone: 8 800 222-88-10

Petrovax Pharm is a Russian company of company of novel biopharmaceutical practices, actively investing in scientific research and development.

The product portfolio includes original pharmaceutical products and vaccines, biotech drugs, and branded generics. The in-house R&D center supports a full cycle of drug development.

The company's complex manufacturing for APIs and finished dosage forms is located in the Moscow region and operates in full compliance with the EAEU and EU GMP standards.

Petrovax’s development strategy focuses on providing patients with in-demand vaccines and drugs for the prevention and treatment of infectious, oncological, and orphan diseases.

Petrovax is implementing international projects with leading pharmaceutical companies: Pfizer, Abbott, ISU ABXIS, Adimmune, Hengrui. The company is one of the largest Russian exporters of original medicines and vaccines to the countries of the EAEU and the EU.

Our mission: Expanding access to cutting-edge therapies

Contact information
Website: www.petrovax.com

The Russian University of Medicine (Rosmedicine) of the Russian Ministry of Health is one of the leading universities in Russia for dental education and training of medical specialists. The university boasts modern academic buildings, clinics, and laboratories, which house seven research and educational institutes.

Across 105 departments, 21 academicians of the Russian Academy of Sciences, 1 academician of the Russian Academy of Education, 21 corresponding members of the Russian Academy of Sciences, over 400 doctors of science, 1,000 candidates of science, 10 honored scientists of the Russian Federation, and 15 laureates of the State Prize, the Presidential Prize, and the Government of Russia share their knowledge with students.

Rosmedicine is a major educational, scientific, and practical center that conducts fundamental, exploratory, and applied scientific research, as well as its experimental and clinical validation. This research is aimed at addressing pressing healthcare issues and introducing innovative approaches to medical practice.

The Russian University of Medicine of the Russian Ministry of Health is part of the Priority program.

Contact information
Website: www.rosunimed.ru

Skolkovo Foundation (part of the VEB.RF Group) is a technology partner for large businesses and one of Russia’s leading innovation centers. The Foundation connects large companies looking for new technologies with technology developers and helps bring these solutions into production.

Skolkovo participant companies develop and supply high-tech Russian products for industries such as manufacturing, healthcare, transport, IT, and others. The Foundation supports companies from the early stages of development to their first industrial contracts. This includes acceleration programs, industry projects, support from private investors, international patenting, and assistance with export and import procedures.

Skolkovo Technopark is the largest technopark in Eastern Europe. Skoltech, the Foundation’s scientific and technology partner, is among the world’s top 100 young universities according to the Nature Index.

In 2025, the total revenue of Skolkovo participant companies grew by 12% to RUB 787.5 billion. The number of participants reached 5,469 companies, up 16.8%, with more than 130,000 people working across the Skolkovo ecosystem.

Contact information
Website: sk.ru

The modern, dynamically developing Russian pharmaceutical company, one of the leaders in the pharmaceutical industry of the Russian Federation in terms of growth rates.

Skopinpharm is a developer and manufacturer of medicines, one of the leading suppliers under the program of 14 high-cost nosologies in accordance with the Ministry of Health of the Russian Federation orders. Skopinpharm offers a range of medications under the regional preferential insurance program, and is also one of the main suppliers of the Circle of Good Foundation for helping children with serious and life-threatening illnesses. The company's turnover amounted to more than 44.0 billion rubles by 2025.

The company operates in the following key areas: manufacture of plasma-derived medicinal products, cytostatics, and medicinal products used for the treatment of various oncological diseases. The company has constructed new manufacturing and storage buildings, performs technology transfer of unique pharmaceutical manufacturing processes, and has built a plasma storage facility with a laboratory unit, which will ensure proper storage for 600 tons of plasma intended for fractionation (raw materials for the manufacture of human plasma-derived medicinal products).

At the same time, in partnership with health authorities, a modern system for the procurement of blood plasma is being created and a voluntary donation program is being developed.

Skopinpharm actively supports the training and advanced training of pharmaceutical industry specialists and is one of the founders of the Academy of Good Practices of the EAEU.

Contact information
Address: Building 1, Industrial Zone No. 1, Skopin District, Ryazan Region, Russia, 391800
E-mail: info@skopinpharm.com
Website: www.skopinpharm.com

Federal State Autonomous Educational Institution of Higher Education « North Caucasus Federal University»

North Caucasus Federal University is a leading scientific and educational center of the North Caucasus Federal District, conducting a wide range of fundamental and applied research. The University has 24 000 students from 85 constituent entities of the Russian Federation and 51 countries worldwide. Since 2021, the University has been a participant in the "Priority-2030" program aimed at creating and developing competitive leading Russian universities that ensure the country's scientific and technological sovereignty and social development.
Key projects of NCFU include:
– the creation of high‑tech production facilities in the field of food biotechnologies in cooperation with “Stavropolsky Dairy Plant”;
– the implementation of innovative solutions for the agro‑industrial complex and the food industry, including a mega‑grant for the creation of an international laboratory in the field of food biotechnologies;
– the development of luminescent ceramics – an innovative material that can replace expensive single crystals in microelectronics, optical instruments and photonics;
– the development of the “Center for New Solutions” engineering development center, which is focused on creating prototypes and trial samples for the production of critically important components.

Contact information
Address: 1 Pushkina Street, Stavropol
Phone: 8 (8652) 33-07-06
Email:  vfadeev@ncfu.ru
Full name and position of the representative: Fadeev Vladimir Aleksandrovich, Vice-Rector for Strategic Development, North Caucasus Federal University

The federal state unitary enterprise "Courier Communication Central Board" was established on August 1, 1939; this day according to the decision of Council of national commissioners of the USSR «About reorganization of courier’s communications of People's Commissariat of Internal Affairs of the USSR», the Service of courier communication started to work. The enterprice was responsible for the transporting service of confidential correspondence and precious metals for all departments, except the top soviet bodies and military narcofloor-mats.

Undoubtedly, transportation of the confidential correspondence and cargoes is a priority task made by the federal state unitary enterprise "Courier Communication Central Board". Along with the primary goal, the federal state unitary enterprise "Courier Communication Central Board" provides other services including reception, processing, storage and delivery of:
The confidential, standard correspondence and cargoes;
Securities, banknotes;
Precious stones, metals and goods made of them;
Jewelry and coins from precious metals;
Cultural and art valuables;
Dangerous and special cargoes;
The weapon and ammunition;
Narcotic and psychotropic medicines.
Much later, almost in 50 years after setting up and numerous renaming, the service was transformed into "Courier Communication Central Board" according to the order of the Ministry of Communications of the USSR from 17.05.1988 № 224. On December, 15th, 1994 Terms of service of courier communication was confirmed by the governmental order of the Russian Federation.

The branches of the federal state unitary enterprise "Courier Communication Central Board" is located in 70 regional areas of Russia. In other settlements of the country there are departments and of our enterprise. Since December, 2008 the department of Courier Communication Central Board operates in Baikonur.

The delivery service completely covers all settlements of Russia, the CIS countries together with and foreign states. Transportations are made by own transport (including on armour cars and the cars supporting a certain temperature), partner relations with large Russian and foreign carriers allow to use any kind of transport for delivery. More than 1 200 routes are being operated today. Cargoes on all transit are accompanied by couriers, armed with the weapon, according to the Federal law from 13.12.1996 № 150-FL «About the weapon». All transported dispatches are insured. The activity of the federal state unitary enterprise "Courier Communication Central Board" is based on the licenses. The federal state unitary enterprise "Courier Communication Central Board" is included in Registers of Customs carriers;

Customs brokers (representatives)
Owners of the temporary storage warehouses

Contact information
Website: cccb.ru/en/

Pharmasyntez Group is one of the leading Russian biopharmaceutical companies operating across various healthcare sectors, including research, production, manufacturing, and distribution of socially significant pharmaceuticals, innovative therapies, and active pharmaceutical ingredients. Pharmasyntez Group operates eight high-tech manufacturing facilities across Russia: in Ussuriysk, Irkutsk, Bratsk, Tyumen, St.Petersburg, Moscow, Kaluga. The annual production volume surpasses 100 million packages. As of 2025, the consolidated revenue of the Pharmasyntez Group reached 50,5 billion rubles. The staff exceeds 6,000 employees. Pharmasyntez develops and manufactures modern pharmaceuticals for a wide range of medical fields, including oncology, hematology, endocrinology, immunology, and cardiology. The company develops and produces pharmaceuticals for orphan diseases, hormonal disorders, infections, autoimmune conditions, cardiovascular diseases, and psychoneurological disorders. The company's portfolio covers therapies for diabetes, tuberculosis, hepatitis, HIV infection, COVID-19, chronic kidney insufficiency, and parenteral nutrition to support patients in critical conditions. Pharmasyntez encompasses one of Russia's largest R&D centers for biotechnological drugs. The company's ongoing research and development endeavors are paving the way for the next generation of innovative therapies for the fields of oncohematology, gynecology, and antiviral treatment. The product portfolio includes over 320 pharmaceutical products. Over 77% of the products manufactured are included in the List of Vital and Essential Drugs (VEDs). Pharmasyntez is the largest investor in the Russian pharmaceutical industry. To date, the company has invested more than 25 billion rubles in the expansion of production facilities and the development of new products.

Contact information
Website: pharmasyntez.com/en

The ChemRar Group is a leading Russian developer and manufacturer of innovative medicines. Its integrated site in the Moscow Region brings together the entire drug development value chain under one roof - from AI-driven drug discovery and preclinical studies to API development, finished dosage form development, regulatory approval, and market launch. ChemRar's innovative product portfolio comprises 8 innovative products already launched in the Russian Federation and a pipeline of 25 candidates at various stages of development. The Group's core therapeutic areas are oncology, oncohematology, central nervous system (CNS) disorders, virology, and cardiometabolic diseases. Our flagship assets include Cyclinza, indicated for the treatment of breast cancer and already available through an Early Access Program (EAP), and Avikras, for the treatment of lung cancer and colorectal cancer. The Group aims to convert its current pipeline into a sustainable flow of Russian-developed therapies that are both accessible to patients and competitive in global markets.

Contact information
Website: www.chemrar.ru

JSC Rosatom Science is a management company for Rosatom’s R&D Unit. Its primary mission is to advance applied and fundamental science within the Russian nuclear industry and to implement R&D results in both domestic and international markets.

Rosatom’s R&D Unit conducts pioneering applied research to develop critical, knowledge-intensive nuclear and non-nuclear technologies; builds the foundation for the Russian nuclear industry and scientific community for decades to come; and fosters the production of innovative products in strategically important industrial sectors, thereby ensuring Russia’s economic sovereignty and sustainable development.

Rosatom scientists address challenges in fusion and technologies that improve quality of life and healthcare; they develop new materials and advance photonics, as well as laser, plasma, and quantum technologies.

Contact information
Website: https://niirosatom.ru/en/

SFedU is a leading higher education institution in the field of biotechnology in southern Russia. To develop research and innovation potential in this area, the university established the Bioengineering of Soils Competence Center. The Center’s mission is to transfer scientific developments into technologies for the bioeconomy, agriculture, and natural resource management. The Center brings together approximately 200 specialists and implements the full cycle—from the diagnosis and design of soil systems to the production of bioproducts, remediation, and monitoring. Its key developments include carbon-based sorbents and nanocomposites, biofertilizers and hydrochars produced from organic raw materials, microbial consortia, the EcoPredict 4.0/EcoConnect digital platforms, robotic sampling, and multispectral mapping. These technologies are aimed at processing biological resources and waste, restoring degraded land, reducing environmental risks, and achieving industrial-scale implementation.

Contact information
Website: https://sfedu.ru/index_eng.php

Contact information
Website:

Contact information
Website: https://astrazeneca.ru/

The Association of Pharmaceutical Companies "Innovative Pharma" (InPharma) brings together major pharmaceutical companies that actively invest in research and development and are counted among the top 20 global pharmaceutical producers.

Members of the Association have research facilities all over the world and also work with Russian R&D centers to conduct clinical trials, cooperating with more than 250 R&D facilities across Russia. Members of the Association carry out research and development in the key fields of medicine, such as cardiology, endocrinology, psychiatry, neurology, oncology, urology, gastroenterology and diabetology. With a view towards developing partnership for innovative pharmaceutical R&D, members of the Association enter into partnership agreements with the Russian development institutions — the Skolkovo Innovation Centre and the Russian Venture Capital Company, as well as develop projects to modernize the biomedicine and biopharmaceutical sectors in Russia, and invest in the construction of manufacturing facilities and research laboratories.

Contact information
Website: https://inpharma.info/en/

Contact information
Website: https://nutrition-institute.ru/en/

CONCERN ESCOM is a dynamically developing leader in the pharmaceutical industry in Russia. Since 1998, the company has been producing infusion solutions, injectable drugs, and medical devices. Over 80% of its products are included in the Vital and Essential Drugs list. The manufacturing facilities are fully modernized in accordance with GMP and ISO standards. More than 30 new drugs are registered annually and Import Substitution Programme is actively being implemented.

Contact information
Address: 9G, Staromaryevskoe hwy, Stavropol, Russia
Chairman of the Board of Directors Gelani Azirov
Telephone: +7(8652)94-68-08
E-mail: info@escom.group
Website: escom.group

Contact information
Telephone: +7 (499) 426-28-87 / +7 (495) 800-77-87
E-mail: info@irwin.ru
Website: https://irwin.ru

SIBUR is one of the fastest growing companies in the global petrochemical industry.
We produce in-demand products for society and use advanced technologies to create new opportunities, invest in social infrastructure, and improve the quality of people’s lives. We evolve through partnership and sharing of experience, continuous growth, pursuit of ambitious goals and commitment to sustainability.
Our products are used in many economic sectors around the world: construction, food industry, medicine and pharmaceuticals, agriculture, automotive and others.

Contact information
Website: sibur.ru/en

Contact information
E-mail: ligno@mfc-k.ru, email@mfc-vl.ru
Website: mfc-vl.ru

Contact information
Website: https://ozonpharm.ru

GEROPHARM is an international producer of biotechnology products. Its’ portfolio includes 40 original medicines and generics. GEROPHARM tops the Russian insulin market and is among the top 10 insulin manufacturers in the world. The Company runs all production stages at its own facilities in Russia by GxP standards. In 2023 GEROPHARM registered Semavic®, Russia's first Ozempic® analog, and in 2025 presented Mounjaro analog – Sejaro®. Medicinal products of the Company are represented in 14 countries.

Contact information
Telephone: +7 (812) 703-79-75
E-mail: inform@geropharm.ru
Website: geropharm.com

Natural artesian water AURUS — the premier ultra-premium bottled water born in Russia. AURUS is produced at the artesian well in the Republic of North Ossetia — Alania right in the heart of Tseysky State Nature Reserve surrounded by pristine nature. Admired for the beautiful exterior, AURUS knows it all about beauty on the inside. Naturally filtered and carefully UV-treated it is bottled in signature glass to deliver a unique hydration experience in any environment.

Contact information
Telephone: +7 (985) 765-55-55
E-mail: info@aurusaqua.ru
Website: www.aurusaqua.ru

Château de Talu is one of the most modern and picturesque wineries on the Russian wine list. It combines the beauty of the nature of the Krasnodar Territory, the southern climate, the traditions of production, winemaking and love for the native land. The complex has already become a price accessory in the tourist cluster of the South of Russia and identified attractions for true connoisseurs of true wine according to the classic canons of French winemaking.

Contact information
Website: https://chateaudetalu.ru

SimplePrivé is a premium wine service of the Simple Group of companies with a unique assortment of wines, spirits and soft drinks and verified personal service.

An individual approach is the hallmark of SimplePrivé. Each client has a personal manager who can solve any problem: from placing orders to searching for collection wines.

There are three levels of privileges in the service: Silver, Gold, and Platinum.

The higher the status, the more benefits you get.

SimplePrivé customers have access to rare vintages and limited editions from the world's best estates, as well as the services of experienced wine experts. Creation and audit of collections, purchases through En Primeur, private tastings and gift solutions on a bespoke project.

Contact information
Website: simplewine.ru/prive

CAUCASIAN BUVETTE LLC is a national producer of natural potable water and soft drinks. Located in Kropotkin, Krasnodar Region, it is an advanced plant with high-tech equipment manufactured by the world's food industry leaders. Comprehensive quality control at all stages is one of our pillars.

Contact information
Telephone: 8-800-500-8-900
E-mail: caucasus@buvette.one
Website: buvette.one

“Dairy company Stavropolskiy” (OAO «MKS») is one of the leading food enterprises in southern Russia. This unique production site manufactures both traditional and innovative dairy products and ingredients. The plant’s capacity allows processing up to 400 tons of raw milk per day. The company’s assortment includes over 500 product names, including import- substituting items: lactose, prebiotic lactulose, protein concentrates, etc. The enterprise employs over 20 PhD holders and maintains constant cooperation with the North Caucasus Federal University. Two high-tech production facility projects have already been implemented.

Contact information
Website: mokostav.com
Phone: +7 (8652) 24-70-95
Email: mokostav@mail.ru, medvetskaya@mokostav.com
Full name and position of the representative: Medvetskaya Anastasia Vladimirovna, Deputy Head of the Technology Department at JSC «Dairy Company Stavropolskiy»

Joint Stock Company "Ryazan State Instrument – making Enterprise" (JSC "RSIE") is part of Joint Stock Company "Concern Radioelectronic Technologies" of the State Corporation "Rostec". The enterprise, founded in 1918, manufactures a wide range of industrial and technical products for various market segments (medical equipment, inverter-type welding equipment, electric charging stations for electric vehicles, electronic engine control systems).

Contact information
Telephone: +7 (4912) 29-85-20, +7 (910) 060-24-03
E-mail: med@grpz.ru, info@grpz.ru
Website: shop.grpz.ru

Elamed was founded in 1980. It manufactures medical furniture, disinfection and sterilization equipment, vacuum systems for venous blood collection, and therapeutic and diagnostic devices. The quality management system is certified to international standards. All products are accompanied by registration certificates from Roszdravnadzor. The company has been among the top three industry leaders for over 10 years. It holds 20 patents for inventions. Exports to 30 countries. Approximately 8,500 medical organizations already use the plant's products.

Contact information
Address: 391351, Ryazan Region, Kasimovsky District, Elatma, Yanina St., 25
Telephone: 8 800 350 06 13
E-mail: lpu@lpu.elamed.com
Website: lpu.elamed.com

Inpharm Research and Production Enterprise was founded in 2016. The company specializes in the development and manufacture of high-quality hyaluronic acid-based medical devices for orthopedics and cosmetology.

The company's product portfolio includes two key brands:
● Hyapro — a line of biopolymer synovial fluid prostheses;
● Hyon — a series of products for injectable cosmetology.

Inpharm actively participates in the import substitution program and closely cooperates with the Ryazan State Medical University named after Academician I.P. Pavlov, conducting joint scientific research and providing employment opportunities for university graduates. Since 2023, the company has been a member of the medical cluster of the Ryazan Region.Consistently high quality, scientifically proven efficacy, and affordability have enabled Inpharm's products to take leading positions in the Russian Federation market and expand internationally. Today, the company is actively developing exports to neighboring countries, including Kyrgyzstan, Uzbekistan, Belarus, and Kazakhstan.

Continuous modernization of production facilities and ongoing research activities allow the enterprise to regularly introduce new innovative products to both Russian and global markets.

Contact information
Telephone: +7 (4912) 70-62-89
E-mail: info@inpharm-hyon.ru
Website: inpharmpro.ru

Today, Ryazan State Medical University is one of Russia’s leading medical universities and an integrated center for education, research, and clinical training. Its graduates pursue successful careers as physicians, epidemiologists, dentists, pharmacists, and psychologists. The University is an international educational center, bringing together students from nearly 60 countries. Its academic programs reflect current developments and standards in medical science and healthcare practice. It also plays an important role in the regional economy, works closely with the pharmaceutical industry, and contributes to the development of the healthcare system.

Contact information
Address: 390026, Ryazan, Vysokovoltnaya St., 9
Telephone: 8-920-9520024
E-mail: rzgmu@rzgmu.ru, alekseyshulkin@rambler.ru

Ryazan Oblast is a region with a unique culture, rich traditions, a dynamically developing economy and a stable social sphere, located in the very heart of the European part of Russia. The main component of the Ryazan Oblast economy is the industrial complex, which accounts for more than a third of the gross regional product. It is predominantly represented by manufacturing industries in such sectors as instrument making, machine tool and mechanical engineering, electronics, petrochemicals and metallurgy. The region also has a well developed production of construction materials, medicines and food products. The growth in the volume of output of hightech, knowledge intensive products, as well as the overall strong scientific and production base, is the result of the substantial presence of enterprises of the defence industrial complex in the region. The existing diversification programmes ensure the development and production of high quality civilian products for a wide range of life activities. The presence of a large number of higher and secondary specialized educational institutions that train specialists for industrial types of economic activity forms the basis for the region’s development and testifies to the high level of human resources potential. The region is home to many historical and cultural landmarks. The Ryazan region is associated with the fates of many outstanding people who brought fame to both their small homeland and the entire country. These include Konstantin Tsiolkovsky, Ivan Pavlov, Sergei Yesenin, and many, many others. The Ryazan region is rightly called the soul of Russia. Hospitality, generosity, openness, and rich creative potential. A business friendly atmosphere. A willingness to engage in productive dialogue. Mutually beneficial economic cooperation. This is what awaits representatives of business circles from Russia and abroad in the Ryazan region. For tourists and visitors to the region, bright discoveries and unforgettable experiences are guaranteed.

Agni medtech – a manufacture of innovative medical equipment for dentistry, surgery, neurosurgery, traumatology, educational medical simulators. Based on global expertise, real-world clinical practice, and industry demands, we create truly unique equipment.

Company Mission
We produce innovative medical equipment, creating harmony in healthcare where doctors'
work is simple and comfortable, clinics are efficient and profitable, and patients are healthy and happy.

Contact information
Telephone: +7 (4912) 46-46-48
E-mail: ceo@agnimt.ru
Website: agnimt.ru

Contact information
Natalia Lobkaeva
Telephone: +7 (929) 555-19-53
Website: artbiolent.ru

“Neva-Bio” LLC develops Russian digital solutions and services for biobanking and the organization of biomedical research. The company has created software for managing biobank collections and is developing it towards a unified digital environment that combines work with biosamples, laboratory research, research data, and the competencies of executing organizations. The company operates at the intersection of biomedicine and information technology, interacting with biobanks, scientific organizations, laboratories, clinical and research centers. The National Platform for Biomedical Research envisages the development of the existing biobank circuit into an infrastructure for organizing comprehensive research involving several independent contractors.

Contact information
Anzhelika Pavlovna Shishkina, Head of Business development
Telephone: 8 (995) 632-97-57
E-mail: info@neva-bio.ru
Website: neva-bio.ru

MyGenetics has been generating personal recommendations aimed to maintain health based on DNA analysis since 2013.

Genetic researches are involved in vital health solutions: personal diet rations, comfortable weight maintenance, skin procedures, sport exercises, detoxification system, stress and anxiety reduction, vitamins correct forms and dosages etc.

Genetic scientists, molecular biologists and medical practitioners are working on DNA report recommendations.

MyGenetics services are used by both private clients and medical centers, clinics, medical practitioners, nutritionists, fitness centers and wellbeing-companies.

Contact information
Address: 630090, Russia, Novosibirsk Region, Novosibirsk, Nikolaeva St., 12, floor/office 6/18
Telephone: 8 (995) 632-97-57
E-mail: info@neva-bio.ru
Website: mygenetics.ru

Since 2011, ORGANIC LOGOS has been engaged in biotechnology research and development. It is the only one company in Russia holding patents covering plant-derived fulvic acid and a method for its determination. The company is ISO-certified and has developed more than 100 dietary supplements and functional ingredients. We obtain active ingredients through a combination of scientific expertise, advanced technology, and practical experience. Our products are exported to more than five countries. We have our own in-house R&D department. Our current research portfolio includes studies confirming the efficacy of our ingredients in terms of antiviral and antibacterial activity, suppression of Mycobacterium tuberculosis, wound healing, and synergistic effects when used in combination with antibiotics.

Contact information
Tatyana Pestova, Executive Director
Telephone: +7 (904) 844-62-33
E-mail: pestova@organiclogos.ru
Website: organiclogos.ru

Contact information
Anna Vladimirovna Vakhrusheva, CEO
Telephone: 8 (985) 617-15-44
E-mail: vakhrusheva@betuvax.ru
Sergey Vladimirovich Masyuk, CEO of Artgen Biotech
Telephone: 8 (917) 572-89-35
Website: betuvax.ru

Rapid Bio is an innovative Russian biotechnology company specializing in the development and manufacturing of diagnostic solutions for laboratory testing, veterinary diagnostics, and food safety.
The company operates a fully integrated development and manufacturing model, covering the entire product lifecycle — from R&D, assay development, and validation to large-scale manufacturing, medical device registration, and market launch. This end-to-end approach enables Rapid Bio to maintain full control over product quality, development timelines, and production scale-up.

Contact information
Telephone: 8 (495) 105-99-16
E-mail: info@rapidbio.ru
Evgeniya Simonova, Chief Project Office
E-mail: esimonova@drdbiotech.ru
Website: rapidbio.ru

Contact information
Kolmakova Maria Evgenievna
Director of Marketing, Co-founder
Telephone: 8 (925) 518-11-19
E-mail: m.kolmakova@ecoartvkus.ru
Grachev Vladimir Borisovich
Director of Production, Co-founder
Telephone: 8 (908) 806-15-51
E-mail: avproizvodstvo@yandex.ru
Website: eco-nad.ru

MEDLEXPROM LLC is a manufacturer of disinfectants and cleaning products under the Medlex brand in Southern Russia.

The product range includes more than 250 items: hand antiseptics, professional disinfection products for healthcare facilities, as well as cleaning and disinfecting products for home use.
The company also provides comprehensive equipment solutions for healthcare facilities and supplies chemical reagents, laboratory glassware, and laboratory instruments.

Contact information
Company MEDLEXPROM LLC
Brand: Medlex
Website: https://medlex.ru/
E-mail: info@medlex.ru
Telephone: +7 861 279-10-00

Contact information
Address: 353411, Krasnodarsky kray, Anapa, s. Supsekh, ul. Kosmonavta Volkova, d. 14, Russian Federation
Anastasiya Sergeyevna Vdovina, General Director
E-mail: info@fitstyle.ru, vdovina@fitstyle.ru
Telephone: 8-800-101-4569, 8 (918) 062-67-93, 8 (903) 451-53-49
Website: fitstyle.ru

_{BONAKA LLC is a Russian manufacturer of microbial feed complexes for livestock farming. In its operations, BONAKA LLC actively applies innovative technologies and develops customized solutions. The company operates its own laboratories and research facilities, where microbial synthesis-based products have been successfully developed since 2015. BONAKA LLC is a 2022 winner of the "Made in Kuban" competition and the recipient of the Grand Prix at the 2024 "Innovative Feed Solutions" competition.}

Contact information
Telephone: +7 861 205 52 99, +7 800 505 28 01
Address: Russia, Krasnodar, Kuznechnaya St., 66
Website: www.apk.bonaka.ru

Since 2009, the team at RIVIERA BIOTEK LLC has specialized in developing and manufacturing medical devices, dietary supplements, and cosmetics. Our brand portfolio includes Urolife, Vita-Hyal, Fitoural, and Prostenol. We also manufacture TM "Baliz-2", a unique line of solutions and suppositories based on comenic acid. This product features a composition and mechanism of action that are unprecedented both in Russia and worldwide. Baliz-2 exhibits powerful antibacterial properties and effectively stimulates the healing of wounds, abrasions, erosions, and other tissue injuries. Due to its combination of high efficacy and absolute safety, Baliz-2 was awarded a Gold Medal by the World Intellectual Property Organization at the Geneva International Exhibition in 1988. Furthermore, the product received first-degree diplomas and gold medals at several prestigious events, including the 2000 "High Technologies. Innovations. Investments" exhibition in St. Petersburg, the 2001 "First International Salon of Innovations and Investments" in Moscow, and the 2004 All-Russian Scientific and Industrial Forum "Russia United" in Nizhny Novgorod.

Contact information
Telephone: +7 (800) 550-00-48
E-mail: info@rivierabiotech.com
Website: rivierabiotech.com